Defining eligible patients for allele-selective chemotherapies targeting NAT2 in colorectal cancer

Rendo V, Kundu S, Rameika N, Ljungström V, Svensson R, Palin K, Aaltonen L, Stoimenov I, Sjöblom T

Sci Rep 10 (1) - [2020-12-00; online 2020-12-31]

Bioinformatics Compute and Storage [Service]

NGI Uppsala (SNP&SEQ Technology Platform) [Service]

National Genomics Infrastructure [Service]

QC bibliography QC xrefs

DOI 10.1038/s41598-020-80288-z

Crossref 10.1038/s41598-020-80288-z